一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

ChemicalBook >> journal list >> Archives of Gynecology and Obstetrics >>article
Archives of Gynecology and Obstetrics

Archives of Gynecology and Obstetrics

IF: 2.1
Download PDF

Depot-medroxyprogesterone acetate: an update

Published:10 May 2008 DOI: 10.1007/s00404-007-0497-z PMID: 18470526
Sayed Bakry, Zaher O. Merhi, Trudy J. Scalise, Mohamad S. Mahmoud, Ahmed Fadiel, Frederick Naftolin

Abstract

Objective

Depo-Provera? is a contraceptive approved by the US Food and Drug Administration (FDA) since 1992 and used worldwide by more than 90 million women.

Aim of study

Despite the fact that progestins are endogenous hormones that are secreted by the body, its excess might lead to detrimental health effects. Whether progestins as contraceptives are friends or foes is a questionable matter. In this manuscript, we drive the attention to both usage and side effects Depo-Provera.

Results

Depot-medroxyprogesterone acetate (DMPA) is a highly effective, convenient non-daily hormonal contraceptive option that has been available worldwide for many years. The experience with DMPA provides a large body of long-term data regarding the efficacy and safety of this contraceptive method; this long-term experience has established that the use of DMPA does not increase the risk of cardiovascular events, breast cancer, other gynecologic malignancy, or postmenopausal fracture; however, patients are often more concerned about the relatively immediate effects of contraceptives such as potential changes in menstrual cycle, body weight, and mood disturbances.

Conclusion

Concerns about such issues may lead to reluctance to initiate therapy or premature discontinuation. Counseling and understanding of women’s concerns and experiences using Depo-Provera is important and could help health care providers redesign counseling strategies to improve contraceptive continuation and improve patient adherence.

Substances (2)

Related products
Procduct Name CAS Molecular Formula Supplier Price
Medroxyprogesterone Acetate 71-58-9 C24H34O4 614 suppliers $12.00-$1590.00
2,2-Bis(hydroxymethyl)propionic acid 4767-03-7 C5H10O4 517 suppliers $6.00-$4084.08

Similar articles

IF:0.2

Pharmacokinetics of depot medroxyprogesterone acetate contraception.

生殖醫(yī)學(xué)雜志 D R Mishell,etc Published: 1 May 1996
IF:3.2

Dutasteride in Androgenetic Alopecia: An Update.

Current clinical pharmacology Tasleem Arif, Konchok Dorjay,etc Published: 1 January 2017
IF:2.8

Praziquantel treatment in trematode and cestode infections: an update.

Infection and Chemotherapy Jong-Yil Chai,etc Published: 1 March 2013
左云县| 香河县| 宜春市| 南丰县| 德庆县| 财经| 六盘水市| 永昌县| 枣庄市| 潞西市| 扶余县| 夏河县| 平塘县| 稻城县| 吉木乃县| 田东县| 行唐县| 宁化县| 泗水县| 商丘市| 鲁山县| 安吉县| 多伦县| 壶关县| 广南县| 长垣县| 闽清县| 鄂温| 桃园县| 那曲县| 中江县| 日照市| 临安市| 乳源| 卫辉市| 正宁县| 成武县| 台中县| 泸定县| 永平县| 沧州市|